Copyright Reports & Markets. All rights reserved.

Global Interventional Lung Disease Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Interventional Lung Disease Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Interventional Lung Disease Consumption 2014-2024
        • 2.1.2 Interventional Lung Disease Consumption CAGR by Region
      • 2.2 Interventional Lung Disease Segment by Type
        • 2.2.1 Bronchoscopes
        • 2.2.2 Respiratory Endotherapy Devices
        • 2.2.3 ENB Systems
        • 2.2.4 Pleuroscopes
        • 2.2.5 Other
      • 2.3 Interventional Lung Disease Consumption by Type
        • 2.3.1 Global Interventional Lung Disease Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Interventional Lung Disease Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Interventional Lung Disease Sale Price by Type (2014-2019)
      • 2.4 Interventional Lung Disease Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Emergency Center
        • 2.4.3 Clinic
      • 2.5 Interventional Lung Disease Consumption by Application
        • 2.5.1 Global Interventional Lung Disease Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Interventional Lung Disease Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Interventional Lung Disease Sale Price by Application (2014-2019)

      3 Global Interventional Lung Disease by Players

      • 3.1 Global Interventional Lung Disease Sales Market Share by Players
        • 3.1.1 Global Interventional Lung Disease Sales by Players (2017-2019)
        • 3.1.2 Global Interventional Lung Disease Sales Market Share by Players (2017-2019)
      • 3.2 Global Interventional Lung Disease Revenue Market Share by Players
        • 3.2.1 Global Interventional Lung Disease Revenue by Players (2017-2019)
        • 3.2.2 Global Interventional Lung Disease Revenue Market Share by Players (2017-2019)
      • 3.3 Global Interventional Lung Disease Sale Price by Players
      • 3.4 Global Interventional Lung Disease Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Interventional Lung Disease Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Interventional Lung Disease Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Interventional Lung Disease by Regions

      • 4.1 Interventional Lung Disease by Regions
        • 4.1.1 Global Interventional Lung Disease Consumption by Regions
        • 4.1.2 Global Interventional Lung Disease Value by Regions
      • 4.2 Americas Interventional Lung Disease Consumption Growth
      • 4.3 APAC Interventional Lung Disease Consumption Growth
      • 4.4 Europe Interventional Lung Disease Consumption Growth
      • 4.5 Middle East & Africa Interventional Lung Disease Consumption Growth

      5 Americas

      • 5.1 Americas Interventional Lung Disease Consumption by Countries
        • 5.1.1 Americas Interventional Lung Disease Consumption by Countries (2014-2019)
        • 5.1.2 Americas Interventional Lung Disease Value by Countries (2014-2019)
      • 5.2 Americas Interventional Lung Disease Consumption by Type
      • 5.3 Americas Interventional Lung Disease Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Interventional Lung Disease Consumption by Countries
        • 6.1.1 APAC Interventional Lung Disease Consumption by Countries (2014-2019)
        • 6.1.2 APAC Interventional Lung Disease Value by Countries (2014-2019)
      • 6.2 APAC Interventional Lung Disease Consumption by Type
      • 6.3 APAC Interventional Lung Disease Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Interventional Lung Disease by Countries
        • 7.1.1 Europe Interventional Lung Disease Consumption by Countries (2014-2019)
        • 7.1.2 Europe Interventional Lung Disease Value by Countries (2014-2019)
      • 7.2 Europe Interventional Lung Disease Consumption by Type
      • 7.3 Europe Interventional Lung Disease Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Interventional Lung Disease by Countries
        • 8.1.1 Middle East & Africa Interventional Lung Disease Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Interventional Lung Disease Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Interventional Lung Disease Consumption by Type
      • 8.3 Middle East & Africa Interventional Lung Disease Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Interventional Lung Disease Distributors
      • 10.3 Interventional Lung Disease Customer

      11 Global Interventional Lung Disease Market Forecast

      • 11.1 Global Interventional Lung Disease Consumption Forecast (2019-2024)
      • 11.2 Global Interventional Lung Disease Forecast by Regions
        • 11.2.1 Global Interventional Lung Disease Forecast by Regions (2019-2024)
        • 11.2.2 Global Interventional Lung Disease Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Interventional Lung Disease Forecast by Type
      • 11.8 Global Interventional Lung Disease Forecast by Application

      12 Key Players Analysis

      • 12.1 Boston Scientific
        • 12.1.1 Company Details
        • 12.1.2 Interventional Lung Disease Product Offered
        • 12.1.3 Boston Scientific Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Boston Scientific News
      • 12.2 Olympus
        • 12.2.1 Company Details
        • 12.2.2 Interventional Lung Disease Product Offered
        • 12.2.3 Olympus Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Olympus News
      • 12.3 FUJIFILM
        • 12.3.1 Company Details
        • 12.3.2 Interventional Lung Disease Product Offered
        • 12.3.3 FUJIFILM Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 FUJIFILM News
      • 12.4 Becton, Dickinson and Company
        • 12.4.1 Company Details
        • 12.4.2 Interventional Lung Disease Product Offered
        • 12.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Becton, Dickinson and Company News
      • 12.5 Smiths Group
        • 12.5.1 Company Details
        • 12.5.2 Interventional Lung Disease Product Offered
        • 12.5.3 Smiths Group Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Smiths Group News
      • 12.6 Cook Medical
        • 12.6.1 Company Details
        • 12.6.2 Interventional Lung Disease Product Offered
        • 12.6.3 Cook Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Cook Medical News
      • 12.7 Vygon
        • 12.7.1 Company Details
        • 12.7.2 Interventional Lung Disease Product Offered
        • 12.7.3 Vygon Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Vygon News
      • 12.8 PENTAX Medical
        • 12.8.1 Company Details
        • 12.8.2 Interventional Lung Disease Product Offered
        • 12.8.3 PENTAX Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 PENTAX Medical News
      • 12.9 Clarus Medical
        • 12.9.1 Company Details
        • 12.9.2 Interventional Lung Disease Product Offered
        • 12.9.3 Clarus Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Clarus Medical News
      • 12.10 HUGER Medical Instrument
        • 12.10.1 Company Details
        • 12.10.2 Interventional Lung Disease Product Offered
        • 12.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 HUGER Medical Instrument News
      • 12.11 Richard Wolf
      • 12.12 Karl Storz
      • 12.13 Taewoong Medical
      • 12.14 ELLA - CS

      13 Research Findings and Conclusion

      Interventional pulmonology is a relatively new field in pulmonary medicine. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest.

      According to this study, over the next five years the Interventional Lung Disease market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional Lung Disease business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Lung Disease market by product type, application, key manufacturers and key regions and countries.

      This study considers the Interventional Lung Disease value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Bronchoscopes
      Respiratory Endotherapy Devices
      ENB Systems
      Pleuroscopes
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospital
      Emergency Center
      Clinic

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Boston Scientific
      Olympus
      FUJIFILM
      Becton, Dickinson and Company
      Smiths Group
      Cook Medical
      Vygon
      PENTAX Medical
      Clarus Medical
      HUGER Medical Instrument
      Richard Wolf
      Karl Storz
      Taewoong Medical
      ELLA - CS

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Interventional Lung Disease consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Interventional Lung Disease market by identifying its various subsegments.
      Focuses on the key global Interventional Lung Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Interventional Lung Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Interventional Lung Disease submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now